. Author manuscript; available in PMC: 2010 Mar 1.

Published in final edited form as: Neurochem Int. 2008 Nov 27;54(3-4):161–171. doi: 10.1016/j.neuint.2008.08.012

Table 2. Average physiological parameters of the rats tested in various treatment groups. The values are given as mean±SD.

	Sham operated groups¹			OBX groups²
	SVV (n=9)	SCV (n=10)	SCP (n=9)	XVV (n=10)	XCV (n=7)	XCP (n=8)
Weight gain (g)	81 ±13^§	82 ±14^§	81 ±11^§	62.2 ±5.4	62 ±17	66 ±22
PaO₂	88.1 ±5.4	92.3 ±2.8	91.1 ±4.6	91 ±10	88.6 ±8.3	88 ±11
PaCO₂	36.8 ±1.8	37.1 ±5.1	41.0 ±3.3	37.3 ±1.9	41.5 ±2.9	39.8 ±3.1
pH	7.45 ±0.02^¶	7.43 ±0.02^†	7.40 ±0.03	7.43 ±0.03^‡	7.40 ±0.02	7.38 ±0.02
Hematocrit (%)	44 ±3	46 ±5	47 ±2	45 ±5	48 ±6	47 ±3
Total Trp (nmol/mL)	43 ±11.0^¶¶	66.4 ±5.2	67.9 ±8.5	45.0 ±7.2	73 ±11^#	67 ±12
Free Trp (nmol/mL)	7.4 ±2.12	9.2 ±2.4	8.9 ±2.5	7.9 ±2.8	8.9 ±2.3	10.3 ±0.9

The sham groups are: SVV, sham rats treated with vehicle for both citalopram and pindolol; SCV, sham rats treated with citalopram and vehicle for pindolol; SCP, sham rats treated with both citalopram and pindolol. n=number of rats per group.

The OBX groups are: XVV, OBX rats treated with vehicle for both citalopram and pindolol; XCV, OBX rats treated with citalopram and vehicle for pindolol; XCP, OBX rats treated with both citalopram and pindolol. n = number of rats per group.

^§

Significantly different from respective OBX group.

^¶

Significantly different from the value in the SCP group.

^¶¶

Significantly different from both SCV and SCP groups

^†

Significantly different from the value in the SCP group.

^‡

Significantly different from the value in the XCP group.

Significantly different from both XVV and XCP groups.